Our Goal

To provide you with the tools needed to make an informed decision. To make cancer manageable and facilitate a better quality of life.

Who We Are

ACT Genomics is an internationally recognized award-winning cancer solution provider. Combining our expertise in the fields of cancer genomics and bioinformatics with our cutting-edge technologies, we are able to assist medical practitioners and scientists with genomics-driven recommendations and data for cancer treatment strategy and discovery.


Our Management Team

Associate Companies


What We Offer

For Patients

Comprehensive genomic profiling allows your doctor to use the results to optimize a treatment plan for you. This approach is known as "precision medicine".

For Medical Professionals

A selection of genomic testing services for major solid tumor types handled through our CAP-accredited laboratory. Our results are delivered within a short TAT for timely treatment planning. 

For Biopharma

Assistance in biomarker discovery and companion diagnostic development by leveraging our cancer genomics databases and know-how. Shorten the process of drug development to commercial launch.

For Research Institutes

Detection and extrapolation of a potential cancer biomarker target by performing deep sequencing coupled with the analysis of multiple cancer genomics databases.




ACT Genomics NGS laboratory opens 08

Establishes bioinformatics platform 10


ACT Genomics Singapore branch opens 10


Acquires CAP (NGS) laboratory certification 04

ACT Genomics Hong Kong branch opens

ACT Genomics forms its subsidiary in Shanghai 09

Receives the Symbol of National Quality in Taiwan 12


ACT Genomics Japan branch opens

ACT Genomics receives Frost & Sullivan Product Line
Strategy Leadership Award (Molecular Diagnostics) 03


ACT Genomics enters into a joint venture with Canon Medical System Corporation named ACTmed 07

ACTOnco®+ receives National Innovation Award in Taiwan 12


ACTmed establishes an analysis laboratory named "Shonan iPark Laboratory" in "Shonan Health Innovation Park" in Kanagawa, Japan 04

ACT Genomics opens third laboratory in Asia at Hong Kong Science & Technology Park

ACT Genomics wins Taiwan Bio Industry Organization Awards- Emerging Company of the Year

ACT Genomics forms a collaboration with AIA Hong Kong to promote precision cancer medicine 07

ACT Genomics wins the Golden Torch Award of "Annual Top 10 Enterprise" in Taiwan 11

ACT Genomics wins 2019 National Innovation Award in Taiwan 12


ACT Genomics partners with Oncoshot to drive clinical trials at a strategic level in Singapore 03

ACT Genomics is the first to receive approval for laboratory-developed NGS tests and services (LDTS) in Taiwan 05

ACT Genomics and Nan Shan Life Insurance cooperate to promote high-quality cancer precision medicine services in Taiwan 09

ACT Genomics becomes a member of The Global Alliance For Genomics And Health (GA4GH)

ACT Genomics acquires ISO/IEC 27001 certification 11


ACT Genomics completes acquisition of MC Diagnostics

ACT Genomics HK Lab Limited acquires CAP Laboratory Certification 06

ACT Genomics receives 2021 Frost & Sullivan Best Practices Award 07

CerbACT Asia – a joint venture between ACT Genomics and Cerba Research – is formed to establish a new and top-notched facility in Taipei 08

ACT Genomics acquires Sanomics 11


ACT Genomics'Thailand subsidiary acquires ISO 15189:2012 accreditation 02

ACT Genomics'Thailand subsidiary acquires ISO 15190:2003 accreditation 04

Prenetics Global Limited (NASDAQ: PRE) acquires a majority stake in ACT Genomics Holdings Company Limited 12


ACT Genomics receives clearance from the U.S. Food and Drug Administration (FDA) for ACTOnco® 01


Join Us

All of us at ACT Genomics are driven to make a difference in this battle against cancer by drawing on our experience from facing cancer at close range. Each of us are devoted to win this fight against cancer. Join us to transform science into actionable solutions!

View our job openings